1/28/2024 0 Comments Anomaly youtubeOn March 27th, AstraZeneca fulfilled its promise by issuing a semi-annual dividend to the investors of record on February 24th. Nonetheless, the company’s solid financials and recent investment activity signal that it could be a good stock to watch over the coming months.ĪstraZeneca: Delivering Value to Investors Through Innovative Healthcare SolutionsĪstraZeneca: A Company that Values its Investors It remains to be seen what led to this recent surge in options trading activity for AstraZeneca on May 8th - whether it was just an anomaly or an indication of something significant remains unclear. Looking forward to the rest of the year, sell-side analysts are predicting earnings per share (EPS) of around $3.66 for AstraZeneca in current fiscal year. They reported earnings per share (EPS) of $0.69 for that quarter, beating consensus estimates by $0.01 per share. In terms of financials, AstraZeneca last issued quarterly earnings results back in February of 2023. Additionally, research firms such as Berenberg Bank and Morgan Stanley have offered positive ratings for the company. Groups such as ICA Group Wealth Management LLC and Parkside Financial Bank & Trust have invested in AZN over the past few months. Recently, institutional investors have added to their stakes in AstraZeneca. The company currently has a market cap of $232.85 billion and is trading at a P/E ratio of nearly 49. Over the past year, AstraZeneca has experienced quite a bit of volatility in its stock price, with a low of $52.65 and a high of $76.56 over the course of the past 52 weeks. Over one million shares were traded that day, compared to the average volume of just under five million shares. ![]() This represents a significant increase of approximately 103% when compared to the average daily volume of 7,947 put options.ĭespite this curious market activity, AZN stock traded up $0.74 during mid-day on May 8th to reach $75.12. ![]() Traders purchased a staggering 16,100 put options on the stock. On May 8th, 2023, AstraZeneca PLC (NASDAQ:AZN) experienced an unusual surge in options trading activity.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |